The BPC-157 + TB-500 + GHK-Cu triple combination covers three distinct repair and regeneration research pathways: localized structural repair (BPC-157/NOS/VEGFR2), systemic anti-inflammatory and stem cell homing (TB-500/actin-sequestering), and extracellular matrix remodeling and collagen signaling (GHK-Cu/ECM/MMP). Together these three mechanisms represent the broadest coverage of tissue repair pathways available in any peptide research combination. QSC supplies all three at ≥99% HPLC with Janoshik independent COA.
What is the BPC-157 + TB-500 + GHK-Cu triple stack?
A three-peptide research combination covering distinct repair mechanisms: BPC-157 (NOS/VEGFR2/EGF, localized structural repair), TB-500 (actin-sequestering Thymosin Beta-4, systemic anti-inflammatory), and GHK-Cu (copper tripeptide, ECM remodeling and collagen synthesis). The three pathways are non-overlapping, providing comprehensive repair research coverage. QSC stocks all three at ≥99% HPLC with Janoshik COA.
What does GHK-Cu add to BPC-157 + TB-500?
BPC-157 and TB-500 address repair initiation (structural repair signaling and systemic anti-inflammatory response). GHK-Cu adds the ECM remodeling layer: collagen synthesis upregulation, MMP rebalancing, and extracellular matrix reconstruction. In tissue models, this represents the ‘finishing’ phase of the repair cascade — rebuilding the structural matrix that supports healed tissue.
Buy BPC-157 + TB-500 + GHK-Cu Triple Research Blend Components
Both compounds available at ≥99% HPLC · Janoshik Independent COA · verify.janoshik.com
Research Use Only: All QSC products sold strictly for in vitro laboratory research. Not for human or veterinary use. Information on this page is educational and does not constitute medical advice.
